China’s Junshi Grants UK Hikma Exclusive Rights to Market New Cancer Drug in Middle East, North Africa
(Yicai Global) Dec. 26 — Shanghai Junshi Biosciences has granted a unit of Britain’s Hikma Pharmaceuticals the exclusive rights to commercialize an innovative cancer drug […]